MoneyWorks4Me

Zydus Lifesciences informs about press release

23 Mar 2024 Evaluate
Zydus Lifesciences has informed that a press release dated March 23, 2024 titled ‘Zydus receives tentative approval from USFDA for Letermovir Tablets, 240 mg and 480 mg’ is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1744.35
Dr. Reddys Labs. 1238.05
Cipla 1324.00
Lupin 1931.40
Zydus Lifesciences 1111.00
View more..